the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052 ·Status: COMPLETED ·Phase: PHASE4

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

NCT00967538 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

NCT05096364 ·Status: COMPLETED ·Phase: PHASE2

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

NCT00833729 ·Status: COMPLETED ·Phase: PHASE4

Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

NCT00317499 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

NCT00800982 ·Status: COMPLETED ·Phase: NA

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT06842199 ·Status: RECRUITING ·Phase: PHASE3

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

NCT04894890 ·Status: COMPLETED

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

NCT02701205 ·Status: UNKNOWN ·Phase: PHASE3

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate

NCT02313922 ·Status: COMPLETED ·Phase: PHASE4

Chinese Psoriasis Real World Evidence Research

NCT04465838 ·Status: RECRUITING

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

NCT06122649 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

NCT01008995 ·Status: COMPLETED ·Phase: PHASE3

Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

NCT00482170 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

NCT06109818 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

NCT05509361 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

NCT01358578 ·Status: COMPLETED ·Phase: PHASE3

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

NCT00322439 ·Status: COMPLETED

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

NCT01690299 ·Status: COMPLETED ·Phase: PHASE3

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

NCT07251998 ·Status: RECRUITING ·Phase: PHASE2

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

NCT05388916 ·Status: COMPLETED